Clinical Trial Update: Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence Tomography [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating the safety and efficacy of zotarolimus- and everolimus-eluting stents using optical coherence tomography in coronary artery di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Endeavor zotarolimus-eluting stent (zotarolimus)
• XIENCE everolimus-eluting stent (everolimus)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Heart Disease | Phase 4 | Status: UNKNOWN